about
Biogen is an established biopharmaceutical company focused on treatments for neurological diseases and rare diseases. Its declining multiple sclerosis franchise is its largest revenue generator and contributed 45% of total revenue in 2024. Biogen als...
Read More
187.04
1.04
(0.56%)
342.7K
XNAS Volume
XNAS 09 Jan, 2026 11:14 AM (EST)
High Financial Strength
Affordable Valuation
Technically Moderately Bullish
Strong Performer
These stock companies have strong financials and are affordably priced. They also score high in quality and technical metrics which make them popular with investors
View Similar
Embed DVM
Biogen Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..